Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free) are designed to treat conditions such as ADHD, Narcolepsy, Depression, and Bipolar Disorder. These capsules are formulated with Methocel E4M, a controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period. This slow release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance, particularly for medications requiring a controlled and prolonged release profile. Importantly, this formulation is gluten-free, catering to those with specific dietary requirements.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free) is a compounded medication designed to treat a range of conditions including Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Sleep Apnea, and Depression. This formulation is uniquely designed with Methocel E4M, a controlled-release polymer, to gradually release the active ingredient, methylphenidate HCl, over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly for medications requiring a controlled and prolonged release profile.
Methylphenidate HCl is a stimulant medication that functions by increasing the levels of dopamine and norepinephrine in the brain. This can significantly improve focus and concentration in individuals with ADHD, reduce fatigue and enhance alertness in those suffering from narcolepsy, improve sleep quality in patients with sleep apnea, and alleviate symptoms of depression.
These capsules are also gluten-free, making them an ideal choice for patients with gluten sensitivities or celiac disease. When taking Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free), it is crucial to adhere to the instructions provided by your healthcare provider. Common side effects may include headache, nausea, insomnia, and decreased appetite. If you experience any severe side effects, it is important to contact your healthcare provider immediately.
If you have any queries about Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free) or its role in treating ADHD, Narcolepsy, Sleep Apnea, or Depression, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the necessary information and support.
This Methylphenidate HCl 60 mg Slow Release Capsules formulation, which is gluten-free, is specifically designed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Sleep Apnea, and Depression. Methylphenidate HCl is a central nervous system stimulant that functions by augmenting the quantity of certain natural substances in the brain that are essential for controlling behavior and attention.
It's crucial to note that this formulation is not recommended for use in children under 6 years of age. Patients should be closely monitored for signs of agitation, irritability, and excessive stimulation. Additionally, the emergence of suicidal thoughts and behaviors should be vigilantly observed.
Patients are advised to abstain from alcohol while taking this formulation. They should also avoid taking other medications that contain methylphenidate or other stimulants concurrently with this formulation. It's important that patients take this formulation as directed by their healthcare provider, with dosage adjustments made according to the patient's response and tolerance.
Patients should promptly inform their healthcare provider if they experience any side effects, such as nausea, vomiting, headache, dizziness, insomnia, or anxiety. If you have any questions about this formulation or its application in treating these disease states, please do not hesitate to reach out.
Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free) is a compounded formulation designed to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Sleep Apnea, and Depression. This medication is formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the active ingredient over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
Being gluten-free, this formulation is also suitable for individuals with gluten sensitivities or allergies. The medication is taken orally, typically once or twice daily, depending on the patient's individual needs and the severity of their condition. It is crucial to adhere to the dosage and administration instructions provided by your healthcare provider.
Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free) works by increasing the levels of certain neurotransmitters in the brain, thereby enhancing focus, concentration, and alertness. It also helps to mitigate impulsivity and hyperactivity, common symptoms in conditions like ADHD.
While generally well-tolerated, some patients may experience side effects such as headache, nausea, insomnia, and decreased appetite. It is essential to discuss any potential side effects with your healthcare provider before starting this medication. If you have any questions about Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free) or its role in treating ADHD, Narcolepsy, Sleep Apnea, and Depression, please consult with your healthcare provider for further information.
Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free) are meticulously formulated with Methocel E4M, a specialized controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism not only reduces the frequency of dosing but also enhances patient compliance, particularly for medications that necessitate a controlled and prolonged release profile.
These capsules are not only limited to treating Attention Deficit Hyperactivity Disorder (ADHD), but they also have a broad spectrum of other potential applications. They have been effectively used in the management of obesity, fatigue, and various sleep disorders. In healthy adults, they have shown promising results in enhancing cognitive performance. For individuals suffering from sleep deprivation, these capsules have been instrumental in reducing fatigue and improving alertness.
Furthermore, Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free) have been used to alleviate the symptoms of jet lag, thereby improving the quality of life for frequent travelers. They have also shown efficacy in improving the quality of life for those suffering from chronic fatigue syndrome. In patients with Tourette's Syndrome, these capsules have been used to reduce symptom severity and improve overall wellbeing.
It is crucial to understand that the dose and duration of treatment with Methylphenidate HCl 60 mg Slow Release Capsules (Gluten Free) should be individualized based on the patient's specific needs. If you have any queries regarding the use of these capsules for any of the aforementioned conditions, please do not hesitate to reach out for further information.
Methylphenidate HCl 60 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the encapsulated medication over an extended period of time, offering sustained therapeutic effects.
The slow release formulation offers sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile. This means that the medication is released gradually over time, reducing the need for frequent dosing and making it easier for patients to adhere to their medication regimen.
Methocel E4M is a type of controlled-release polymer used in the formulation of this medication. It is designed to gradually release the encapsulated medication over an extended period of time.
Yes, Methylphenidate HCl 60 mg Slow Release Capsules are gluten free, making them suitable for individuals with gluten intolerance or celiac disease.
Due to its slow release formulation, the frequency of dosing for Methylphenidate HCl 60 mg Slow Release Capsules may be reduced. However, the exact dosing schedule should be determined by your healthcare provider based on your specific needs and condition.
Methylphenidate HCl 60 mg Slow Release Capsules offer sustained therapeutic effects due to their slow release formulation. This means that the medication continues to work over an extended period of time, providing ongoing treatment for the condition it is prescribed for.
Yes, the slow release formulation of Methylphenidate HCl 60 mg Slow Release Capsules is designed to improve patient compliance. This is because the reduced dosing frequency makes it easier for patients to adhere to their medication regimen.
A controlled and prolonged release profile means that the medication is released gradually over an extended period of time. This offers sustained therapeutic effects and reduces the need for frequent dosing.
Methylphenidate HCl 60 mg Slow Release Capsules should only be taken under the supervision of a healthcare provider. It is important to discuss your medical history and any other medications you are taking with your healthcare provider before starting this medication.
If you miss a dose of Methylphenidate HCl 60 mg Slow Release Capsules, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses. Always consult your healthcare provider if you have any questions or concerns.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth